MYST Trademark

Trademark Overview

On Thursday, June 20, 2019, a trademark application was filed for MYST with the United States Patent and Trademark Office. The USPTO has given the MYST trademark a serial number of 88481183. The federal status of this trademark filing is ABANDONED - AFTER EX PARTE APPEAL as of Thursday, April 1, 2021. This trademark is owned by Myst Therapeutics, Inc.. The MYST trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors; pharmaceutical preparation for T Cell therapy; biological preparations for the treatment of cancer and tumors
myst

General Information

Serial Number88481183
Word MarkMYST
Filing DateThursday, June 20, 2019
Status603 - ABANDONED - AFTER EX PARTE APPEAL
Status DateThursday, April 1, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicespharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors; pharmaceutical preparation for T Cell therapy; biological preparations for the treatment of cancer and tumors

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, June 30, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMyst Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90066

Trademark Events

Event DateEvent Description
Thursday, January 12, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 2, 2021ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Thursday, April 1, 2021ABANDONMENT - AFTER EX PARTE APPEAL
Thursday, April 1, 2021EXPARTE APPEAL TERMINATED
Wednesday, February 10, 2021CASE ASSIGNED TO TTAB
Thursday, January 28, 2021EXPARTE APPEAL TERMINATED
Monday, November 16, 2020NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Monday, November 16, 2020ACTION DENYING REQ FOR RECON E-MAILED
Monday, November 16, 2020ACTION CONTINUING FINAL - COMPLETED
Tuesday, November 10, 2020DIVISIONAL PROCESSING COMPLETE
Thursday, September 3, 2020DIVISIONAL REQUEST RECEIVED
Thursday, October 29, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 7, 2020EX PARTE APPEAL-INSTITUTED
Wednesday, October 7, 2020JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, October 7, 2020EXPARTE APPEAL RECEIVED AT TTAB
Thursday, October 1, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 30, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 30, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, September 3, 2020TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, April 8, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, April 8, 2020FINAL REFUSAL E-MAILED
Wednesday, April 8, 2020FINAL REFUSAL WRITTEN
Wednesday, March 18, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 18, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 18, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 19, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 19, 2019NON-FINAL ACTION E-MAILED
Thursday, September 19, 2019NON-FINAL ACTION WRITTEN
Thursday, September 12, 2019ASSIGNED TO EXAMINER
Sunday, June 30, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 24, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

myst pharmaceutical treatment cancer preparations tumors products therapy cell biological namely